Mohammad Reza Dawoudi is currently working as CEO at Finno Bio Stock Oy. Author’s significant publications include “Neurocognitive, Biological and Genetics factors and the Risk of Developing Borderline Intellectual Functioning (BIF) Disease among Kurdish Societies”. Author current research interests include Intelligence Quotient and Neurocognitive.